Seidu S, Cos X, Brunton S, Harris S B, Jansson S P O, Mata-Cases M, Neijens A M J, Topsever P, Khunti K
Diabetes Research Centre, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, United Kingdom.
Sant Marti de Provenҫals Primary Care Centres, Institut Català de la Salut, University Research Institute in Primary Care (IDIAP Jordi Gol), Barcelona, Spain.
Prim Care Diabetes. 2022 Apr;16(2):223-244. doi: 10.1016/j.pcd.2022.02.002. Epub 2022 Feb 16.
Type 2 diabetes and its associated comorbidities are growing more prevalent, and the complexity of optimising glycaemic control is increasing, especially on the frontlines of patient care. In many countries, most patients with type 2 diabetes are managed in a primary care setting. However, primary healthcare professionals face the challenge of the growing plethora of available treatment options for managing hyperglycaemia, leading to difficultly in making treatment decisions and contributing to treatment and therapeutic inertia. This position statement offers a simple and patient-centred clinical decision-making model with practical treatment recommendations that can be widely implemented by primary care clinicians worldwide through shared-decision conversations with their patients. It highlights the importance of managing cardiovascular disease and elevated cardiovascular risk in people with type 2 diabetes and aims to provide innovative risk stratification and treatment strategies that connect patients with the most effective care.
2型糖尿病及其相关合并症日益普遍，优化血糖控制的复杂性不断增加，尤其是在患者护理的第一线。在许多国家，大多数2型糖尿病患者在初级保健机构接受管理。然而，初级保健专业人员面临着管理高血糖的可用治疗方案过多的挑战，这导致难以做出治疗决策，并导致治疗和治疗惰性。本立场声明提供了一个简单且以患者为中心的临床决策模型以及实用的治疗建议，全球初级保健临床医生可通过与患者进行共同决策对话广泛实施。它强调了管理2型糖尿病患者心血管疾病和心血管风险升高的重要性，并旨在提供创新的风险分层和治疗策略，将患者与最有效的护理联系起来。
